| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/04/2010 | US20100028449 Fermented milk product and use thereof |
| 02/04/2010 | US20100028435 Injectable hydrogel with an enhanced remanence and with an enhanced ability to create volume |
| 02/04/2010 | US20100028418 Gainac specific binding molecules and uses thereof |
| 02/04/2010 | US20100028355 Himf and btk in pulmonary, cardiac and inflammation disorders |
| 02/04/2010 | US20100028350 Preventing il-2 mediated inflammation in epithelial cells |
| 02/04/2010 | US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 02/04/2010 | US20100028345 Il-17 receptor a antigen binding proteins |
| 02/04/2010 | US20100028313 Compositions and methods for treatment of skin disorders |
| 02/04/2010 | US20100028298 Interferon type i supporting compounds |
| 02/04/2010 | US20100028263 Methods for inhibiting mast cell activation and treating mast cell-dependent inflammatory diseases and disorders using lactobacillus |
| 02/04/2010 | US20100028257 Pharmaceutical compounds |
| 02/04/2010 | CA2738510A1 6-substituted isoflavonoid compounds and uses thereof |
| 02/04/2010 | CA2732715A1 Treatment agent or preventative agent for osteoarthritis |
| 02/04/2010 | CA2732282A1 Aminopropylidene derivative |
| 02/04/2010 | CA2730770A1 Diazepan and piperazine derivatives modulators of chemokine receptors |
| 02/04/2010 | CA2730659A1 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 02/04/2010 | CA2729578A1 Phenanthrenone compounds, compositions and methods |
| 02/03/2010 | EP2149558A1 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino-1-arylquinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 02/03/2010 | EP2149552A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors |
| 02/03/2010 | EP2148862A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk |
| 02/03/2010 | EP2148657A2 Process for obtaining steroidal phosphate compounds |
| 02/03/2010 | EP1511742B1 Kinase inhibitors |
| 02/03/2010 | CN100586444C Method of processing ginseng for medicinal use and composition |
| 02/02/2010 | US7655802 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs |
| 02/02/2010 | US7655797 Intermediates for making 2,4-pyrimidinediamine compounds |
| 02/02/2010 | US7655780 Integrin-linked kinase and its uses |
| 02/02/2010 | US7655688 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 02/02/2010 | US7655687 Anti-inflammatory analgesic for external use |
| 02/02/2010 | US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 02/02/2010 | US7655651 Biphenyl-4-carboxylic acid (4-chloro-3-{7-[4-(2-diethylamino-ethoxy)-phenylamino]-1-methyl-2-oxo-1,4-dihydro-2H-pyrimido[4,5-d]pyrimidin-3-yl}-phenyl)-amide; protein kinase inhibitors |
| 02/02/2010 | US7655637 N-pyrazole A2A receptor agonists |
| 02/02/2010 | US7655628 Method for treating liver cirrhosis or interstitial pulmonary fibrosis |
| 02/02/2010 | US7655624 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 02/02/2010 | US7655617 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 02/02/2010 | US7655616 Traumatic brain and spinal cord injury treatment; administering interleukin-1B converting enzyme (capsase-1) inhibitor |
| 02/02/2010 | US7655261 Medicament and method of treatment of patients with heavy metals |
| 02/02/2010 | CA2530159C N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
| 02/02/2010 | CA2494583C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/02/2010 | CA2439051C Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 02/02/2010 | CA2424186C Antimicrobial compositions formulated for use in cold temperature conditions and methods of use thereof |
| 02/02/2010 | CA2418868C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 02/02/2010 | CA2396158C Dipeptide nitrile cathepsin k inhibitors |
| 02/02/2010 | CA2383412C Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 02/02/2010 | CA2324418C Novel opiate compounds, methods of making and methods of use |
| 02/02/2010 | CA2321819C Xylitol compositions for treating upper respiratory conditions |
| 02/02/2010 | CA2257973C T cell antigen receptor peptides |
| 02/02/2010 | CA2180425C Purified primate ctla-8 antigens and related reagents |
| 01/28/2010 | WO2010011772A2 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 01/28/2010 | WO2010011619A1 Large substituent, non-phenolic amine opioids |
| 01/28/2010 | WO2010011533A2 Compositions and methods for increasing serum antioxidant concentrations |
| 01/28/2010 | WO2010011325A2 Synthesis and utilization of small molecules for the treatment of inflammation associated with interleukin-1 signaling |
| 01/28/2010 | WO2010011296A2 Deacetylase inhibitors and uses thereof |
| 01/28/2010 | WO2010011147A1 Indole compounds |
| 01/28/2010 | WO2010010934A1 Heterocyclidene derivative having p-substituted arylacetamide |
| 01/28/2010 | WO2010010346A2 Topical compositions for use during tooth eruption |
| 01/28/2010 | WO2010010288A2 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof |
| 01/28/2010 | WO2010010189A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/28/2010 | WO2010010187A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/28/2010 | WO2010010184A1 [1, 2, 4] triazolo [1, 5-a] pyridines as jak inhibitors |
| 01/28/2010 | WO2010010112A2 Construct and method for the internalization of cargo molecules into a cell |
| 01/28/2010 | WO2010009814A1 5-[ (3,3,3-trifluoro-2-hydroxy-1-arylpropyl) amino]-1-arylquinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 01/28/2010 | WO2009132454A8 Di-t-butylphenyl piperazines as calcium channel blockers |
| 01/28/2010 | WO2009132452A8 Diaryl-cyclylalkyl derivatives as calcium channel blockers |
| 01/28/2010 | WO2009129456A3 Alpha adrenergic receptor agonists for treatment of inflammatory diseases |
| 01/28/2010 | WO2009129149A4 Drug depots having different release profiles for reducing, preventing or treating pain and inflammation |
| 01/28/2010 | US20100022783 Cyclohexanecarboxylic acid compound |
| 01/28/2010 | US20100022650 Benzamide Derivatives As EP4 Receptor Agonists |
| 01/28/2010 | US20100022643 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 01/28/2010 | US20100022614 Pharmaceutical composition for external application and adhesive skin patch |
| 01/28/2010 | US20100022612 Fused heterocycles |
| 01/28/2010 | US20100022611 1,5-Diaryl-Pyrazoles As Cannabinoid Receptor Neutral Antagonists Useful As Therapeutic Agents |
| 01/28/2010 | US20100022595 Benzenesulfonamide Compounds and Their Use as Blockers of Calcium Channels |
| 01/28/2010 | US20100022582 Tetrahydroisoquinoline Compound and Medicinal Use Thereof |
| 01/28/2010 | US20100022571 Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors |
| 01/28/2010 | US20100022561 Inhibitors of bruton's tyrosine kinase |
| 01/28/2010 | US20100022555 Novel Derivatives |
| 01/28/2010 | US20100022548 Use of n-heterocyclylmethylbenzamides in therapeutics |
| 01/28/2010 | US20100022540 Triazole derivatives ii |
| 01/28/2010 | US20100022537 I-pheny 1-3,4-dihydropyrimidin-2(1h)-one derivatives and their use |
| 01/28/2010 | US20100022536 Inhibitors of Cytosolic Phospholipase A2 |
| 01/28/2010 | US20100022528 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use |
| 01/28/2010 | US20100022522 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 01/28/2010 | US20100022491 4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7yl compounds for modulation of b2-adrenoreceptor activity |
| 01/28/2010 | US20100022448 Peptides |
| 01/28/2010 | US20100021991 Methods for Producing Modified Glycoproteins |
| 01/28/2010 | US20100021516 Drug depots having one or more anchoring members |
| 01/28/2010 | US20100021493 Extracts of aphanizomenon flos aquae and nutritional, cosmetic and pharmaceutical compositons containing the same |
| 01/28/2010 | US20100021451 Uses and compositions for treatment of ankylosing spondylitis |
| 01/28/2010 | US20100021430 Horse feed and treatment methods |
| 01/28/2010 | CA2731880A1 Compositions for the treatment of pain and/or inflammation |
| 01/28/2010 | CA2731789A1 Alkyl thiazole carbamate derivatives, preparation thereof, and use thereof as faah enzyme inhibitors |
| 01/28/2010 | CA2731730A1 Deacetylase inhibitors and uses thereof |
| 01/28/2010 | CA2731463A1 Compositions and methods for increasing serum antioxidant concentrations |
| 01/28/2010 | CA2731432A1 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 01/28/2010 | CA2731429A1 Large substituent, non-phenolic amine opioids |
| 01/27/2010 | EP2147683A1 Construct and method for the internalization of cargo molecules into a cell |
| 01/27/2010 | EP2147673A1 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 01/27/2010 | EP2146988A1 New 4,8-diphenyl-polyazanaphthalene derivatives |
| 01/27/2010 | EP2146983A1 Pyrazoles useful in the treatment of inflammation |
| 01/27/2010 | EP2146967A2 Tetrahydroindole and tetrahydroindazole derivatives |